BOSTON, Massachusetts, Sept. 12 (TNSjou) -- Harvard Medical School issued the following news:

* * *

Targeting CDK2 Could Boost Cancer Immunotherapy Response

Findings in mice suggest blocking protein can reduce resistance to immune checkpoint inhibitors

By DANA-FARBER COMMUNICATIONS September 11, 2026

At a glance

* Study suggests CDK2 inhibitors, currently being tested to slow cell growth in a few types of cancer, could . . .

Click here for more information about our products